The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing

Leukemia

Volumn 28, Issue 11, 2014, Pages 2241-2272

  Liu, Y ^a   Razak, F R Abdul ^a   Terpstra, M ^a   Chan, F C ^b   Saber, A ^a   Nijland, M ^a   Van Imhoff, G ^a   Visser, L ^a   Gascoyne, R ^b   Steidl, C ^b   Kluiver, J ^a   Diepstra, A ^a   Kok, K ^a   Van Den Berg, A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; HLA ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 2; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTOME;

ANTIGEN EXPRESSION; APOPTOSIS; BCL6 GENE; BURKITT LYMPHOMA; CELL ADHESION; CELL DIFFERENTIATION; CELL MATURATION; CIITA GENE; CREBBP GENE; CYLD GENE; DIFFUSE LARGE B CELL LYMPHOMA; EP300 GENE; FAT GENE; FOLLICULAR LYMPHOMA; GENE IDENTIFICATION; GENE MUTATION; GENE ONTOLOGY; GENETIC VARIABILITY; HIST1H1E GENE; HODGKIN DISEASE; HODGKIN LYMPHOMA CELL LINE; INTERMETHOD COMPARISON; JAK-STAT SIGNALING; JAK2 GENE; KM-H2 CELL LINE; L-1236 CELL LINE; L-428 CELL LINE; L-540 CELL LINE; LETTER; MAP3K14 GENE; MLL2 GENE; MLL3 GENE; MUC GENE; NFKBI GENE; NFKBIA GENE; NFKBIE GENE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTPN1 GENE; REED STERNBERG CELL; REL GENE; RNA SEQUENCE; SANGER SEQUENCING; SOCS1 GENE; SUPHD1 CELL LINE; TNFAIP3 GENE; VALIDATION PROCESS; WHOLE EXOME SEQUENCING; EXOME; GENE EXPRESSION REGULATION; GENETICS; HUMAN; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

CELL LINE, TUMOR; DNA MUTATIONAL ANALYSIS; EXOME; GENE EXPRESSION REGULATION, NEOPLASTIC; HODGKIN DISEASE; HUMANS; TRANSCRIPTOME;

EID: 84919349611     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.201     Document Type: Letter

References (14)

1. Kuppers R, Engert A, Hansmann ML. Hodgkin lymphoma. J Clin Invest 2012; 122: 3439-3447.
2. Gunawardana J, Chan F, Telenius A, Woolcock BW, Kridel R, Tan KL et al. Exomewide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma. Nat Genet 2014; 46: 352-356.
3. Morris LG, Ramaswami D, Chan TA. The FAT epidemic: a gene family frequently mutated across multiple human cancer types. Cell Cycle 2013; 12: 1011-1012.
4. Yin H, Liang Y, Yan Z, Liu B, Su Q. Mutation spectrum in human colorectal cancers and potential functional relevance. BMC Med Genet 2013; 14: 32.
5. Zhang J, Mullighan CG, Harvey RC, Pearson SA, Walters RJ, Nagler B et al. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2011; 118: 3080-3087.
6. Diepstra A, Poppema S, Boot M, Visser L, Nolte IM, Niens M et al. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma. Tissue Antigens 2008; 71: 219-226.
7. Steidl C, Shah SP, Woolcock BW, Rui L, Kawahara M, Farinha P et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 2011; 471: 377-381.
8. Zhang J, Grubor V, Love CL, Banerjee A, Richards KL, Mieczkowski PA et al. Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 2013; 110: 1398-1403.
9. Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011; 476: 298-303.
10. Morin RD, Mungall K, Pleasance E, Mungall AJ, Goya R, Huff RD et al. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood 2013; 122: 1256-1265.
11. Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011; 43: 830-837.
12. Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci USA 2012; 109: 3879-3884.
13. Green MR, Gentles AJ, Nair RV, Irish JM, Kihira S, Liu CL et al. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood 2013; 121: 1604-1611.
14. Richter J, Schlesner M, Hoffmann S, Kreuz M, Leich E, Burkhardt B et al. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet 2012; 44: 1316-1320.